Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

Désirée van der Heijde, Ben A. C. Dijkmans, Piet Geusens et al. · Arthritis & Rheumatism · 2005 · 861 citations

Medicine, Pharmacology, Pharmacotherapy +14

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

John C. Davis, Désirée van der Heijde, Jürgen Braun et al. · Arthritis & Rheumatism · 2003 · 763 citations

Medicine, Immunology, Pharmacotherapy +8

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

Robert D. Inman, John C. Davis, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2008 · 593 citations

Medicine, Clinical Sciences, Pharmacotherapy +7

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Robert Landewé, Jürgen Braun, Atul Deodhar et al. · Annals of the Rheumatic Diseases · 2013 · 468 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11

2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis

Désirée van der Heijde, Joachim Sieper, Walter P. Maksymowych et al. · Annals of the Rheumatic Diseases · 2011 · 410 citations

Medicine, Clinical Sciences, Pharmacotherapy +12